Nov 29 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- TGA APPROVAL OF NOVEL ORAL CONTRACEPTIVE NEXTSTELLIS
- THERAPEUTIC GOODS ADMINISTRATION APPROVED NOVEL COMBINED ORAL CONTRACEPTIVE NEXTSTELLIS
- ANTICIPATES COMMERCIAL LAUNCH OF NEXTSTELLIS BY MID-2022
News: MYX Mayne Pharma Says Therapeutic Goods Administration Approved Novel Combined Oral...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.08 | $5.02 | $395.8K | 78.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $5.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 3084 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |